Literature DB >> 2864639

Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.

B Lemmer, H Winkler, T Ohm, M Fink.   

Abstract

Comparative pharmacokinetic studies with the beta-receptor blocking drugs propranolol, metoprolol, sotalol and atenolol, differing greatly in lipophilicity, and their main route of elimination were performed in light-dark-synchronized rats after equimolar single (6 mumoles/kg) or multiple (6 X 6 mumoles/kg) drug application. Drug concentrations were determined in plasma and various target organs of the drugs, e.g. heart, muscle, lung and brain, after drug application in the light period (L) and dark period (D), respectively. After single drug administration pharmacokinetic parameters of all drugs depended on the L and D conditions. Elimination half-lives in plasma and organs were shorter during D than during L. No L-D-differences were found in initial drug concentrations of the hydrophilic drugs sotalol and atenolol. In contrast, C0-values of the lipophilic propranolol in highly perfused organs (muscle, lung, brain) and of metoprolol in muscle tissue were significantly higher in D than in L. No obvious temporal dependency was found in other pharmacokinetic parameters (AUC, plasma clearance, Vd beta) with the exception in Vd beta of propranolol. Due to the different physico-chemical properties of the compounds inter-drug-differences in pharmacokinetic parameters including drug accumulation into lung and brain tissue were observed. Multiple drug dosing abolished the circadian-phase-dependency in the elimination half-lives of the drugs due to an increase in D. Only for the highly lipophilic propranolol half-lives in highly perfused organs were still shorter in D than in L.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864639     DOI: 10.1007/bf00586708

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  33 in total

1.  The disposition of propranolol. IV. A dominant role for tissue uptake in the dose-dependent extraction of propranolol by the perfused rat liver.

Authors:  G H Evans; G R Wilkinson; D G Shand
Journal:  J Pharmacol Exp Ther       Date:  1973-09       Impact factor: 4.030

2.  A simple method for recording the electrocardiogram and heart rate from conscious animals.

Authors:  J B Farmer; G P Levy
Journal:  Br J Pharmacol Chemother       Date:  1968-01

3.  [Diurnal variations evidence of glomerular filtration in the rat (author's transl)].

Authors:  J Cambar; F Lemoigne; C Toussaint
Journal:  Experientia       Date:  1979-12-15

4.  Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.

Authors:  D Hellenbrecht; B Lemmer; G Wiethold; H Grobecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.

Authors:  H C Brown; S G Carruthers; G D Johnston; J G Kelly; J McAinsh; D G McDevitt; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875

6.  Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.

Authors:  H I Pirttiaho; E A Sotaniemi; R O Pelkonen; U Pitkänen; M Anttila; H Sundqvist
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

7.  Differences in the content and turnover of noradrenaline in rat heart atria and ventricles and circadian-phase-dependency.

Authors:  B Lemmer; R Weimer
Journal:  Experientia       Date:  1983-09-15

8.  Antagonism by chlorisondamine and propranolol, but not by atenolol, of the circadian phase-dependent phentolamine-induced changes in the cardiac noradrenaline turnover in the rat.

Authors:  B Lemmer; A Charrier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

9.  Circadian organization of thirteen liver and six brain enzymes of the mouse.

Authors:  C North; R J Feuers; L E Scheving; J E Pauly; T H Tsai; D A Casciano
Journal:  Am J Anat       Date:  1981-11

10.  High-performance liquid chromatographic method for the quantitative analysis of the aryloxypropanolamines propranolol, metoprolol and atenolol in plasma and tissue.

Authors:  H Winkler; W Ried; B Lemmer
Journal:  J Chromatogr       Date:  1982-03-12
View more
  11 in total

1.  Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.

Authors:  M A van Baak; J M Mooij; P M Schiffers
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Clinical chronopharmacology of oral sustained-release isosorbide-5-mononitrate in healthy subjects.

Authors:  B Lemmer; B Scheidel; H Blume; H J Becker
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects.

Authors:  B Langner; B Lemmer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  A Combination of G Protein-Coupled Receptor Modulators Protects Photoreceptors from Degeneration.

Authors:  Tivadar Orban; Henri Leinonen; Tamar Getter; Zhiqian Dong; Wenyu Sun; Songqi Gao; Alexander Veenstra; Hossein Heidari-Torkabadi; Timothy S Kern; Philip D Kiser; Krzysztof Palczewski
Journal:  J Pharmacol Exp Ther       Date:  2017-11-21       Impact factor: 4.030

5.  Effects of salbutamol upon performance on an operant screen for antidepressants.

Authors:  R T Dunn; J B Richards; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  The effect of oxprenolol dosage time on its pharmacokinetics and haemodynamic effects during exercise in man.

Authors:  R Koopmans; B Oosterhuis; J M Karemaker; J Wemer; C J van Boxtel
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  A Potential Link between the C5a Receptor 1 and the β1-Adrenoreceptor in the Mouse Heart.

Authors:  Kuan Hua Khor; Tyson A Moore; Ian A Shiels; Ristan M Greer; Thiruma V Arumugam; Paul C Mills
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

Review 8.  Therapeutic applications of circadian rhythms for the cardiovascular system.

Authors:  Elena V Tsimakouridze; Faisal J Alibhai; Tami A Martino
Journal:  Front Pharmacol       Date:  2015-04-17       Impact factor: 5.810

9.  Severe hypoglycemia-induced sudden death is mediated by both cardiac arrhythmias and seizures.

Authors:  Candace M Reno; Allie Skinner; Justin Bayles; Y Stefanie Chen; Dorit Daphna-Iken; Simon J Fisher
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-02-27       Impact factor: 4.310

10.  The use of α- or β-blockers to ameliorate the chronic stress of captivity in the house sparrow (Passer domesticus).

Authors:  Clare Parker Fischer; L Michael Romero
Journal:  Conserv Physiol       Date:  2016-10-15       Impact factor: 3.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.